Functions of S100 proteins.

The S100 protein family consists of 24 members functionally distributed into three main subgroups: those that only exert intracellular regulatory effects, those with intracellular and extracellular functions and those which mainly exert extracellular regulatory effects. S100 proteins are only expressed in vertebrates and show cell-specific expression patterns. In some instances, a particular S100 protein can be induced in pathological circumstances in a cell type that does not express it in normal physiological conditions. Within cells, S100 proteins are involved in aspects of regulation of proliferation, differentiation, apoptosis, Ca2+ homeostasis, energy metabolism, inflammation and migration/invasion through interactions with a variety of target proteins including enzymes, cytoskeletal subunits, receptors, transcription factors and nucleic acids. Some S100 proteins are secreted or released and regulate cell functions in an autocrine and paracrine manner via activation of surface receptors (e.g. the receptor for advanced glycation end-products and toll-like receptor 4), G-protein-coupled receptors, scavenger receptors, or heparan sulfate proteoglycans and N-glycans. Extracellular S100A4 and S100B also interact with epidermal growth factor and basic fibroblast growth factor, respectively, thereby enhancing the activity of the corresponding receptors. Thus, extracellular S100 proteins exert regulatory activities on monocytes/macrophages/microglia, neutrophils, lymphocytes, mast cells, articular chondrocytes, endothelial and vascular smooth muscle cells, neurons, astrocytes, Schwann cells, epithelial cells, myoblasts and cardiomyocytes, thereby participating in innate and adaptive immune responses, cell migration and chemotaxis, tissue development and repair, and leukocyte and tumor cell invasion.

[1]  R. Moritz,et al.  Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10. , 1993, Journal of immunology.

[2]  A. Bresnick,et al.  Integrin α6β4 Controls the Expression of Genes Associated with Cell Motility, Invasion, and Metastasis, Including S100A4/Metastasin* , 2009, Journal of Biological Chemistry.

[3]  B. Wolska-Kuśnierz,et al.  Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism , 2002, The Lancet.

[4]  Rihua Zhang,et al.  Identification of S100A16 as a novel adipogenesis promoting factor in 3T3-L1 cells. , 2011, Endocrinology.

[5]  I. Weissman,et al.  Mouse MRP8 and MRP14, two intracellular calcium-binding proteins associated with the development of the myeloid lineage. , 1992, Blood.

[6]  M. Sakaguchi,et al.  S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes , 2008, Journal of cellular biochemistry.

[7]  D. Waisman,et al.  S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. , 2005, Frontiers in bioscience : a journal and virtual library.

[8]  M. Goebeler,et al.  Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments. , 1995, The Biochemical journal.

[9]  J. Luban,et al.  Blockade of Late Stages of Autoimmune Diabetes by Inhibition of the Receptor for Advanced Glycation End Products1 , 2004, The Journal of Immunology.

[10]  I. Plante,et al.  Myeloid-Related Proteins Rapidly Modulate Macrophage Nitric Oxide Production during Innate Immune Response1 , 2008, The Journal of Immunology.

[11]  F. Michetti,et al.  Saliva S100B in professional sportsmen: High levels at resting conditions and increased after vigorous physical activity. , 2011, Clinical biochemistry.

[12]  R. Donato,et al.  S100B and S100A1 proteins in bovine retina: their calcium-dependent stimulation of a membrane-bound guanylate cyclase activity as investigated by ultracytochemistry , 1999, Neuroscience.

[13]  R. Donato,et al.  S-100 protein, but not calmodulin, binds to the glial fibrillary acidic protein and inhibits its polymerization in a Ca(2+)-dependent manner. , 1993, The Journal of biological chemistry.

[14]  Helene K Myrvang,et al.  Design, Synthesis, and Structure−Activity Relationship Exploration of 1-Substituted 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-one Analogues as Inhibitors of the Annexin A2−S100A10 Protein Interaction , 2011, Journal of medicinal chemistry.

[15]  Carolyn L. Geczy,et al.  Inflammation-associated S100 proteins: new mechanisms that regulate function , 2011, Amino Acids.

[16]  I. Ekiel,et al.  Metastasis-associated Protein S100A4 Induces Angiogenesis through Interaction with Annexin II and Accelerated Plasmin Formation* , 2005, Journal of Biological Chemistry.

[17]  C. Heizmann,et al.  S100B and S100A6 Differentially Modulate Cell Survival by Interacting with Distinct RAGE (Receptor for Advanced Glycation End Products) Immunoglobulin Domains* , 2007, Journal of Biological Chemistry.

[18]  R. Sprengelmeyer,et al.  S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. , 1997, Stroke.

[19]  Laura E. Thompson,et al.  The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography. , 2010, Journal of molecular biology.

[20]  M. Manns,et al.  S100A9 a new marker for monocytic human myeloid‐derived suppressor cells , 2012, Immunology.

[21]  K. Blennow,et al.  Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury , 2008, Acta Neurochirurgica.

[22]  C. Heizmann The multifunctional S100 protein family. , 2002, Methods in molecular biology.

[23]  I. Nagaoka,et al.  Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation , 2008, Immunology.

[24]  J. Palefsky,et al.  Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro , 2007, Journal of leukocyte biology.

[25]  T. Beems,et al.  GFAP and S100B are biomarkers of traumatic brain injury , 2010, Neurology.

[26]  R. Donato Binding of Chlorpromazine to S‐100 Protein , 1984, Journal of neurochemistry.

[27]  T. Ruzicka,et al.  Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium , 2007, Experimental dermatology.

[28]  A. Bresnick,et al.  Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products. , 2006, Arthritis and rheumatism.

[29]  Roy M. Williams,et al.  S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression , 2011, Molecular Cancer Research.

[30]  C. Heizmann,et al.  Binding of S100 proteins to RAGE: an update. , 2009, Biochimica et biophysica acta.

[31]  E. Ellis,et al.  S100B protein is released from rat neonatal neurons, astrocytes, and microglia by in vitro trauma and anti‐S100 increases trauma‐induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons , 2007, Journal of neurochemistry.

[32]  W. Nacken,et al.  Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. , 2001, Biochemistry.

[33]  G. Wakabayashi,et al.  Changes in Serum S100A12 and sRAGE Associated with Improvement of the PaO2/FiO2 Ratio following PMX-DHP Therapy for Postoperative Septic Shock , 2011, European Surgical Research.

[34]  T. Ruzicka,et al.  S100A15, an antimicrobial protein of the skin: regulation by E. coli through Toll-like receptor 4. , 2007, The Journal of investigative dermatology.

[35]  M. Grigorian,et al.  S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. , 2007, Cardiovascular research.

[36]  N. Hogg,et al.  The S100 Family Heterodimer, MRP-8/14, Binds with High Affinity to Heparin and Heparan Sulfate Glycosaminoglycans on Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[37]  D. Souza,et al.  Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study , 2002, European Neuropsychopharmacology.

[38]  R. Murphy,et al.  Determination of leukotriene A4 stabilization by S100A8/A9 proteins using mass spectrometry , 2009, Journal of Lipid Research.

[39]  T. Leanderson,et al.  S100A9 Interaction with TLR4 Promotes Tumor Growth , 2012, PloS one.

[40]  M. Völkers,et al.  Cardiac S100A1 Protein Levels Determine Contractile Performance and Propensity Toward Heart Failure After Myocardial Infarction , 2006, Circulation.

[41]  Yasuo Kubota,et al.  Identification of intracellular target proteins of the calcium-signaling protein S100A12. , 2004, European journal of biochemistry.

[42]  W. Nacken,et al.  Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. , 2008, Arthritis and rheumatism.

[43]  Eric P. Skaar,et al.  Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus. , 2011, Cell host & microbe.

[44]  David J Weber,et al.  S100A1: Structure, Function, and Therapeutic Potential. , 2009, Current chemical biology.

[45]  M. Raftery,et al.  Oxidative modifications of S100 proteins: functional regulation by redox , 2009, Journal of leukocyte biology.

[46]  R. Donato,et al.  S100B/RAGE-dependent activation of microglia via NF-κB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1β and TNF-α , 2010, Neurobiology of Aging.

[47]  D. Souza,et al.  The ischemic rat heart releases S100B. , 2005, Life sciences.

[48]  M. Sakaguchi,et al.  PKCα mediates TGFβ-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11 , 2004, The Journal of cell biology.

[49]  S. Mocellin,et al.  The prognostic value of serum S100B in patients with cutaneous melanoma: A meta‐analysis , 2008, International journal of cancer.

[50]  S. Yuspa,et al.  Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function , 2011, Amino Acids.

[51]  B. Bogerts,et al.  S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation , 2008, Neuroscience.

[52]  K. Schroder,et al.  Probing the S100 protein family through genomic and functional analysis. , 2004, Genomics.

[53]  J. Schröder,et al.  Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection , 2005, Nature Immunology.

[54]  L. V. Eldik,et al.  Secretion of S-100 from rat C6 glioma cells , 1987, Brain Research.

[55]  Peter P. Liu,et al.  S100B Expression Modulates Left Ventricular Remodeling After Myocardial Infarction in Mice , 2005, Circulation.

[56]  M. Raftery,et al.  Oxidative modifications of DAMPs suppress inflammation: the case for S100A8 and S100A9. , 2011, Antioxidants & redox signaling.

[57]  P. Libby,et al.  Loss of Myeloid Related Protein-8/14 Exacerbates Cardiac Allograft Rejection , 2011, Circulation.

[58]  R. Terkeltaub,et al.  Transamidation by Transglutaminase 2 Transforms S100A11 Calgranulin into a Procatabolic Cytokine for Chondrocytes1 , 2008, The Journal of Immunology.

[59]  N. van Regemorter,et al.  S‐100 protein in amniotic fluid of anencephalic fetuses , 1984, Prenatal diagnosis.

[60]  Tae Hyong Kim,et al.  Integrin (α6β4) Signals Through Src to Increase Expression of S100A4, a Metastasis-Promoting Factor: Implications for Cancer Cell Invasion , 2009, Molecular Cancer Research.

[61]  I. Lednev,et al.  Hexameric Calgranulin C (S100A12) Binds to the Receptor for Advanced Glycated End Products (RAGE) Using Symmetric Hydrophobic Target-binding Patches* , 2006, Journal of Biological Chemistry.

[62]  David J Weber,et al.  The Calcium-binding Protein S100B Down-regulates p53 and Apoptosis in Malignant Melanoma* , 2010, The Journal of Biological Chemistry.

[63]  K. Neve,et al.  Novel Interaction of the Dopamine D2 Receptor and the Ca2+ Binding Protein S100B: Role in D2 Receptor Function , 2008, Molecular Pharmacology.

[64]  G. Shaw,et al.  Unique S100 target protein interactions. , 2009, General physiology and biophysics.

[65]  K. Gaus,et al.  S100A8 and S100A9 in Human Arterial Wall , 2005, Journal of Biological Chemistry.

[66]  C. Dobson,et al.  Amyloid Formation by the Pro-Inflammatory S100A8/A9 Proteins in the Ageing Prostate , 2009, PloS one.

[67]  F. Michetti,et al.  The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients , 1979, Neuroscience Letters.

[68]  R. Donato,et al.  S-100 protein-induced changes in the physical state of synaptosomal particulate fractions as monitored by spin labels. , 1985, Archives of biochemistry and biophysics.

[69]  I. Ishikawa,et al.  S100A4 inhibition by RNAi up-regulates osteoblast related genes in periodontal ligament cells. , 2004, Biochemical and biophysical research communications.

[70]  G. Arendash,et al.  Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease , 2009, Glia.

[71]  N. Miwa,et al.  Characterization of S100A11, a suppressive factor of fertilization, in the mouse female reproductive tract , 2011, Molecular reproduction and development.

[72]  K. Bornfeldt,et al.  S100A9 Differentially Modifies Phenotypic States of Neutrophils, Macrophages, and Dendritic Cells: Implications for Atherosclerosis and Adipose Tissue Inflammation , 2011, Circulation.

[73]  Yoko Takahashi,et al.  HOXC6 and HOXC11 increase transcription of S100β gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into Schwannian cells , 2007, Journal of cellular and molecular medicine.

[74]  Arne Skerra,et al.  The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins. , 2007, Journal of molecular biology.

[75]  R. Donato,et al.  S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK , 2006, Journal of cellular physiology.

[76]  C. Delphin,et al.  The Giant Protein AHNAK Is a Specific Target for the Calcium- and Zinc-binding S100B Protein , 2001, The Journal of Biological Chemistry.

[77]  Zhong-Gao Xu,et al.  Key Role of Src Kinase in S100B-induced Activation of the Receptor for Advanced Glycation End Products in Vascular Smooth Muscle Cells* , 2006, Journal of Biological Chemistry.

[78]  R. L. Pagano,et al.  Involvement of proteinase-activated receptors 1 and 2 in spreading and phagocytosis by murine adherent peritoneal cells: modulation by the C-terminal of S100A9 protein. , 2010, European journal of pharmacology.

[79]  I. Thorey,et al.  MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. , 2004, Blood.

[80]  R. Jonsson,et al.  Effects of Human Calprotectin (L1) on In Vitro Immunoglobulin Synthesis , 1994, Scandinavian journal of immunology.

[81]  J. Brisman,et al.  Reliability of S100B in predicting severity of central nervous system injury , 2007, Neurocritical care.

[82]  R. Caprioli,et al.  Tissue profiling MALDI mass spectrometry reveals prominent calcium‐binding proteins in the proteome of regenerative MRL mouse wounds , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[83]  J. Tsoporis,et al.  Expression of S100A6 in Cardiac Myocytes Limits Apoptosis Induced by Tumor Necrosis Factor-α* , 2008, Journal of Biological Chemistry.

[84]  W. Nacken,et al.  Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein , 2008, The Journal of experimental medicine.

[85]  M. Buchfelder,et al.  The Passage of S100B from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity , 2010, Cardiovascular psychiatry and neurology.

[86]  R. Donato,et al.  The Danger Signal S100B Integrates Pathogen– and Danger–Sensing Pathways to Restrain Inflammation , 2011, PLoS pathogens.

[87]  R. Ryall,et al.  Comparison of the specific incorporation of intracrystalline proteins into urinary calcium oxalate monohydrate and dihydrate crystals. , 2010, Journal of proteome research.

[88]  Arnold D K Hill,et al.  Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected]. , 2010, Cancer research.

[89]  R. Donato Chlorpromazine inhibits the calcium-mediated effects of S-100 protein(s) on assembled brain microtubule proteins, but not those on microtubule protein assembly. , 1984, Biochemical and biophysical research communications.

[90]  M. Grigorian,et al.  Epidermal growth factor receptor ligands as new extracellular targets for the metastasis‐promoting S100A4 protein , 2009, The FEBS journal.

[91]  Katsuyoshi Miyama,et al.  Fibroblast growth-stimulating activity of S100A9 (MRP-14). , 2004, European journal of biochemistry.

[92]  M. Hennerici,et al.  Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke , 1997, Journal of the Neurological Sciences.

[93]  N. Horie,et al.  Appearance of nuclear factors that interact with genes for myeloid calcium binding proteins (MRP-8 and MRP-14) in differentiated HL-60 cells , 1993 .

[94]  David J Weber,et al.  The Calcium-Dependent Interaction between S100B and the Mitochondrial AAA ATPase ATAD3A and the Role of This Complex in the Cytoplasmic Processing of ATAD3A , 2010, Molecular and Cellular Biology.

[95]  I. H. Engels,et al.  Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. , 2003, The American journal of pathology.

[96]  M. Tremblay,et al.  HIV-1 Transcription and Virus Production Are Both Accentuated by the Proinflammatory Myeloid-Related Proteins in Human CD4+ T Lymphocytes1 , 2002, The Journal of Immunology.

[97]  C. Heizmann,et al.  S100A16, a Novel Calcium-binding Protein of the EF-hand Superfamily* , 2006, Journal of Biological Chemistry.

[98]  D. Foell,et al.  The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer , 2009, Journal of leukocyte biology.

[99]  S. Yui,et al.  Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. , 2003, Biological & pharmaceutical bulletin.

[100]  Norifumi Ueda,et al.  Modulation of S‐100 genes response to growth conditions in human epithelial tumor cells , 1997, Pathology international.

[101]  D. Hilt,et al.  The S100 protein family. , 1988, Trends in biochemical sciences.

[102]  M Ikura,et al.  Diversity of conformational states and changes within the EF‐hand protein superfamily , 1999, Proteins.

[103]  Edwin Pozharski,et al.  In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction. , 2010, International journal of high throughput screening.

[104]  G. Wakabayashi,et al.  Significance of Measuring S100A12 and sRAGE in the Serum of Sepsis Patients with Postoperative Acute Lung Injury , 2010, Digestive Surgery.

[105]  J. K. Muir,et al.  S100B protein is released by in vitro trauma and reduces delayed neuronal injury , 2004, Journal of neurochemistry.

[106]  R. Donato,et al.  S100B protein in myoblasts modulates myogenic differentiation via NF‐κB‐dependent inhibition of MyoD expression , 2010, Journal of cellular physiology.

[107]  T. Araki,et al.  Expression of S‐100 protein is related to neuronal damage in MPTP‐treated mice , 2003, Glia.

[108]  W. Chazin,et al.  Target selectivity in EF-hand calcium binding proteins. , 2004, Biochimica et biophysica acta.

[109]  M. Lackmann,et al.  S100 protein CP‐10 stimulates myeloid cell chemotaxis without activation , 1996, Journal of cellular physiology.

[110]  R. Donato,et al.  S100B Inhibits Myogenic Differentiation and Myotube Formation in a RAGE-Independent Manner , 2003, Molecular and Cellular Biology.

[111]  C. Gottfried,et al.  A simple, sensitive and widely applicable ELISA for S100B: Methodological features of the measurement of this glial protein , 2008, Journal of Neuroscience Methods.

[112]  C. Heizmann,et al.  The importance of Ca2+/Zn2+ signaling S100 proteins and RAGE in translational medicine. , 2011, Frontiers in bioscience.

[113]  B. Camoretti-Mercado,et al.  Transgenic expression of human S100A12 induces structural airway abnormalities and limited lung inflammation in a mouse model of allergic inflammation , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[114]  A. Petros,et al.  Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[115]  Zhihua Liu,et al.  Involvement of S100A14 Protein in Cell Invasion by Affecting Expression and Function of Matrix Metalloproteinase (MMP)-2 via p53-dependent Transcriptional Regulation* , 2012, The Journal of Biological Chemistry.

[116]  K. Schulze-Osthoff,et al.  MRP 8 / MRP 14 impairs endothelial integrity and induces a caspase-dependent and-independent cell death program , 2007 .

[117]  M. Rothermundt,et al.  S100B in schizophrenia: an update. , 2009, General physiology and biophysics.

[118]  P. Hart,et al.  S100A8 induction in keratinocytes by ultraviolet A irradiation is dependent on reactive oxygen intermediates. , 2003, The Journal of investigative dermatology.

[119]  M. Raftery,et al.  S-Glutathionylation Regulates Inflammatory Activities of S100A9* , 2010, The Journal of Biological Chemistry.

[120]  C. Geczy,et al.  IL-10-Dependent S100A8 Gene Induction in Monocytes/Macrophages by Double-Stranded RNA1 , 2009, The Journal of Immunology.

[121]  C. Geczy,et al.  Acute inflammatory activity of the S100 protein CP-10. Activation of neutrophils in vivo and in vitro. , 1994, Journal of immunology.

[122]  D. Mayer,et al.  S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. , 2006, Experimental cell research.

[123]  L. V. Van Eldik,et al.  The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. , 2003, Restorative neurology and neuroscience.

[124]  Yasuhiro Ito,et al.  S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. , 2008, Current cancer drug targets.

[125]  P. Most,et al.  S100A1: A Multifaceted Therapeutic Target in Cardiovascular Disease , 2010, Journal of cardiovascular translational research.

[126]  F. Murad,et al.  Upregulation of S100 calcium‐binding protein A9 is required for induction of smooth muscle cell proliferation by a periodontal pathogen , 2009, FEBS letters.

[127]  J. Hentschel,et al.  Rad54B targeting to DNA double-strand break repair sites requires complex formation with S100A11. , 2008, Molecular biology of the cell.

[128]  W. Chazin,et al.  Subversion of antimicrobial calprotectin (S100A8/S100A9 complex) in the cytoplasm of TR146 epithelial cells after invasion by Listeria monocytogenes , 2009, Mucosal Immunology.

[129]  P. Schirmacher,et al.  S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis , 2009, Hepatology.

[130]  B. Haller,et al.  MRP8/14 is associated with systemic inflammation in stable coronary atherosclerosis in men , 2011, European journal of clinical investigation.

[131]  Yi-Ching Lee,et al.  Lack of an Endogenous Anti-inflammatory Protein in Mice Enhances Colonization of B16F10 Melanoma Cells in the Lungs* , 2010, The Journal of Biological Chemistry.

[132]  Jens Pietzsch,et al.  Human S100A12: a novel key player in inflammation? , 2009, Amino Acids.

[133]  P. Angel,et al.  S100A8 and S100A9 in inflammation and cancer. , 2006, Biochemical pharmacology.

[134]  W. Trojaborg,et al.  Antagonism of RAGE suppresses peripheral nerve regeneration , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[135]  T. Petrova,et al.  Modulation of glial activation by astrocyte-derived protein S100B: differential responses of astrocyte and microglial cultures , 2000, Brain Research.

[136]  C. Gottfried,et al.  Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[137]  Lianfeng Zhang,et al.  S100B transgenic mice develop features of Parkinson's disease. , 2011, Archives of medical research.

[138]  P. Greengard,et al.  p11 (S100A10)--an inducible adaptor protein that modulates neuronal functions. , 2007, Current opinion in pharmacology.

[139]  U. Rescher,et al.  S100A10/p11: family, friends and functions , 2007, Pflügers Archiv - European Journal of Physiology.

[140]  David J Weber,et al.  Inhibiting S100B Restores p53 Levels in Primary Malignant Melanoma Cancer Cells* , 2004, Journal of Biological Chemistry.

[141]  D. Pechkovsky,et al.  Calprotectin (MRP8/14 protein complex) release during mycobacterial infection in vitro and in vivo. , 2000, FEMS immunology and medical microbiology.

[142]  G. Miller,et al.  Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[143]  J. Saurat,et al.  A Heterocomplex Formed by the Calcium-binding Proteins MRP8 (S100A8) and MRP14 (S100A9) Binds Unsaturated Fatty Acids with High Affinity* , 1997, The Journal of Biological Chemistry.

[144]  Herbert J Zeh,et al.  Journal of Translational Medicine BioMed Central Review , 2009 .

[145]  R. Natarajan,et al.  Distinct Roles of Heterogeneous Nuclear Ribonuclear Protein K and microRNA-16 in Cyclooxygenase-2 RNA Stability Induced by S100b, a Ligand of the Receptor for Advanced Glycation End Products*♦ , 2008, Journal of Biological Chemistry.

[146]  D. Costea,et al.  S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9. , 2011, European journal of cancer.

[147]  C. Müller-Tidow,et al.  Characterization of the Ca2+-regulated Ezrin-S100P Interaction and Its Role in Tumor Cell Migration* , 2008, Journal of Biological Chemistry.

[148]  G. Lyons,et al.  Transcriptional regulation of S100A1 and expression during mouse heart development. , 2000, Biochimica et biophysica acta.

[149]  Adriana B Ferreira,et al.  S100β Induces Neuronal Cell Death Through Nitric Oxide Release from Astrocytes , 1997, Journal of neurochemistry.

[150]  S E Mikkelsen,et al.  S100A12 protein is a strong inducer of neurite outgrowth from primary hippocampal neurons , 2001, Journal of neurochemistry.

[151]  M. Kapoor,et al.  Evidence for Annexin II-S100A10 Complex and Plasmin in Mobilization of Cytokine Activity of Human TrpRS* , 2008, Journal of Biological Chemistry.

[152]  P. Roy,et al.  Interaction of Calpactin Light Chain (S100A10/p11) and a Viral NS Protein Is Essential for Intracellular Trafficking of Nonenveloped Bluetongue Virus , 2011, Journal of Virology.

[153]  A. Waring,et al.  Calcitermin, a novel antimicrobial peptide isolated from human airway secretions , 2001, FEBS letters.

[154]  H. Huttunen,et al.  Coregulation of Neurite Outgrowth and Cell Survival by Amphoterin and S100 Proteins through Receptor for Advanced Glycation End Products (RAGE) Activation* , 2000, The Journal of Biological Chemistry.

[155]  M. Grigorian,et al.  Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity , 2004, Oncogene.

[156]  H. Huttunen,et al.  S100B Interaction With the Receptor for Advanced Glycation End Products (RAGE): A Novel Receptor-Mediated Mechanism for Myocyte Apoptosis Postinfarction , 2010, Circulation research.

[157]  P. Rudland,et al.  S100P Dissociates Myosin IIA Filaments and Focal Adhesion Sites to Reduce Cell Adhesion and Enhance Cell Migration* , 2012, The Journal of Biological Chemistry.

[158]  W. Nacken,et al.  Loss of S100A9 (MRP14) Results in Reduced Interleukin-8-Induced CD11b Surface Expression, a Polarized Microfilament System, and Diminished Responsiveness to Chemoattractants In Vitro , 2003, Molecular and Cellular Biology.

[159]  W. Nacken,et al.  The calcium binding protein S100A9 is essential for pancreatic leukocyte infiltration and induces disruption of cell–cell contacts , 2008, Journal of cellular physiology.

[160]  M. Boerries,et al.  Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. , 2004, The Journal of clinical investigation.

[161]  R. Huber,et al.  S100A1 and S100B interactions with annexins. , 2000, Biochimica et biophysica acta.

[162]  D. Souza,et al.  Increased serum S100B protein in schizophrenia: a study in medication-free patients. , 2001, Journal of psychiatric research.

[163]  S. Sakiyama,et al.  Expression of a calcium binding protein pEL98 (mts1) during differentiation of human promyelocytic leukemia HL-60 cells. , 1994, Biochemical and Biophysical Research Communications - BBRC.

[164]  C. Yu,et al.  S100A13-lipid interactions-role in the non-classical release of the acidic fibroblast growth factor. , 2007, Biochimica et biophysica acta.

[165]  P. Bertics,et al.  Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B. , 2011, International immunology.

[166]  L. Salamonsen,et al.  Endometrial calbindins are critical for embryo implantation: evidence from in vivo use of morpholino antisense oligonucleotides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[167]  Kathleen C. Lee,et al.  S100A7 (Psoriasin)--mechanism of antibacterial action in wounds. , 2007, The Journal of investigative dermatology.

[168]  David J Weber,et al.  Phenothiazines inhibit S100A4 function by inducing protein oligomerization , 2010, Proceedings of the National Academy of Sciences.

[169]  F. Michetti,et al.  Human milk contains S100B protein. , 2003, Biochimica et biophysica acta.

[170]  P. Svenningsson,et al.  S100A10 regulates plasminogen-dependent macrophage invasion. , 2010, Blood.

[171]  M. Khrestchatisky,et al.  RAGE–TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion , 2010, Journal of Cell Science.

[172]  G. Arendash,et al.  Overexpression of Human S100B Exacerbates Brain Damage and Periinfarct Gliosis After Permanent Focal Ischemia , 2008, Stroke.

[173]  W. Chazin,et al.  S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3 , 2010, Cell Research.

[174]  R. Anderson,et al.  High serum S100B levels for trauma patients without head injuries. , 2001, Neurosurgery.

[175]  R. Stockley,et al.  Myeloid related protein-8/14 stimulates interleukin-8 production in airway epithelial cells. , 2003, American journal of respiratory cell and molecular biology.

[176]  M. Fujita,et al.  Intrinsic function of S100A8/A9 complex as an anti-inflammatory protein in liver injury induced by lipopolysaccharide in rats. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[177]  R. Donato,et al.  S100B binding to RAGE in microglia stimulates COX‐2 expression , 2007, Journal of leukocyte biology.

[178]  R. Donato,et al.  S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.

[179]  M. Mildner,et al.  Flagellin is the principal inducer of the antimicrobial peptide S100A7c (psoriasin) in human epidermal keratinocytes exposed to Escherichia coli , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[180]  J. Hugnot,et al.  Expression of S100B during embryonic development of the mouse cerebellum , 2007, BMC Developmental Biology.

[181]  A. Schmidt,et al.  The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. , 2001, The Journal of clinical investigation.

[182]  R. Donato,et al.  S100B Engages RAGE or bFGF/FGFR1 in Myoblasts Depending on Its Own Concentration and Myoblast Density. Implications for Muscle Regeneration , 2012, PloS one.

[183]  R. L. Pagano,et al.  Macrophage suppression following phagocytosis of apoptotic neutrophils is mediated by the S100A9 calcium-binding protein. , 2010, Immunobiology.

[184]  F. Michetti,et al.  Increased S100B in cerebrospinal fluid of infants with bacterial meningitis: relationship to brain damage and routine cerebrospinal fluid findings. , 2004, Clinical chemistry.

[185]  D. Stern,et al.  Understanding RAGE, the receptor for advanced glycation end products , 2005, Journal of Molecular Medicine.

[186]  B. Nielsen,et al.  Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors. , 2010, Cancer research.

[187]  W. Nacken,et al.  Computational searches for missing orthologs: the case of S100A12 in mice. , 2004, Omics : a journal of integrative biology.

[188]  B. Fleischmann,et al.  S100A1 Enhances the L-type Ca2+ Current in Embryonic Mouse and Neonatal Rat Ventricular Cardiomyocytes* , 2005, Journal of Biological Chemistry.

[189]  A. Mebazaa,et al.  Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. , 2012, Clinical chemistry.

[190]  D. Foell,et al.  Mechanisms of Disease: a 'DAMP' view of inflammatory arthritis , 2007, Nature Clinical Practice Rheumatology.

[191]  R. Donato,et al.  Annexin VI binds S100A1 and S100B and blocks the ability of S100A1 and S100B to inhibit desmin and GFAP assemblies into intermediate filaments. , 1998, Cell calcium.

[192]  C. Delphin,et al.  S100B expression defines a state in which GFAP‐expressing cells lose their neural stem cell potential and acquire a more mature developmental stage , 2007, Glia.

[193]  L. J. Eldik,et al.  S100 beta induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. , 1996, Biochimica et biophysica acta.

[194]  R. Donato,et al.  S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. , 2004, Biochimica et biophysica acta.

[195]  C. Psachoulia,et al.  INCREASED LEVELS OF SERUM S100B PROTEIN IN CRITICALLY ILL PATIENTS WITHOUT BRAIN INJURY , 2006, Shock.

[196]  D. Scudiero,et al.  S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells , 2011, Molecular biology of the cell.

[197]  R. Landewé,et al.  Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis , 2008, Annals of the rheumatic diseases.

[198]  S. Yuspa,et al.  Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A151 , 2008, The Journal of Immunology.

[199]  P. Rudland,et al.  The basic C-terminal amino acids of calcium-binding protein S100A4 promote metastasis. , 2008, Carcinogenesis.

[200]  P. Greengard,et al.  A Role for p11 in the Antidepressant Action of Brain-Derived Neurotrophic Factor , 2010, Biological Psychiatry.

[201]  K. Kamiguchi,et al.  A Calcium Binding Protein, S100A4, Mediates T Cell Dependent Cytotoxicity as a Transformation‐Associated Antigen , 2005, Microbiology and immunology.

[202]  F. Michetti,et al.  S100b counteracts effects of the neurotoxicant trimethyltin on astrocytes and microglia , 2005, Journal of neuroscience research.

[203]  D. Foell,et al.  Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function , 2009, BMC Biochemistry.

[204]  W. Chazin,et al.  S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. , 2009, European journal of pharmacology.

[205]  L. J. Eldik,et al.  Mechanism of glial activation by S100B: involvement of the transcription factor NFκB , 2001, Neurobiology of Aging.

[206]  F. Nishimura,et al.  Migration Inhibitory Factor Related Protein-8 (MRP-8) is an Autocrine Chemotactic Factor for Periodontal Ligament Cells , 1999, Journal of dental research.

[207]  L. Murphy,et al.  The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer. , 2005, Cancer research.

[208]  Gene Kim,et al.  S100A12 Mediates Aortic Wall Remodeling and Aortic Aneurysm , 2010, Circulation research.

[209]  J. Sacher,et al.  Mood Disorders Are Glial Disorders: Evidence from In Vivo Studies , 2010, Cardiovascular psychiatry and neurology.

[210]  M. Nomoto,et al.  Zonisamide-induced long-lasting recovery of dopaminergic neurons from MPTP-toxicity , 2011, Brain Research.

[211]  Jian Cai,et al.  Myeloid-Related Protein-14 Is a p38 MAPK Substrate in Human Neutrophils1 , 2005, The Journal of Immunology.

[212]  K. Wilson,et al.  Structure of the human S100A12-copper complex: implications for host-parasite defence. , 2003, Acta crystallographica. Section D, Biological crystallography.

[213]  P. Rouleau,et al.  The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. , 2003, Clinical immunology.

[214]  D. Richardson,et al.  S-Nitrosylated S100A8: Novel Anti-Inflammatory Properties1 , 2008, The Journal of Immunology.

[215]  P. Watson,et al.  S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer , 2010, Oncogene.

[216]  Jens Pietzsch,et al.  S100A2 in cancerogenesis: a friend or a foe? , 2011, Amino Acids.

[217]  W. B. van den Berg,et al.  S100A8 causes a shift toward expression of activatory Fcγ receptors on macrophages via toll-like receptor 4 and regulates Fcγ receptor expression in synovium during chronic experimental arthritis. , 2010, Arthritis and rheumatism.

[218]  R. Donato,et al.  Effects of S100A1 and S100B on microtubule stability. An in vitro study using triton-cytoskeletons from astrocyte and myoblast cell lines , 2000, Neuroscience.

[219]  J. Roder,et al.  Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice. , 2000, Experimental cell research.

[220]  R. Donato,et al.  Interaction of S-100b protein with cardiolipin vesicles as monitored by electron spin resonance, pyrene fluorescence and circular dichroism. , 1988, Cell calcium.

[221]  F. Rahimi,et al.  Regulation of S100A8 by Glucocorticoids1 , 2005, The Journal of Immunology.

[222]  C. Heizmann,et al.  The crystal structures of human S100B in the zinc- and calcium-loaded state at three pH values reveal zinc ligand swapping. , 2011, Biochimica et biophysica acta.

[223]  R. Loeser,et al.  Interleukin-7 stimulates secretion of S100A4 by activating the JAK/STAT signaling pathway in human articular chondrocytes. , 2009, Arthritis and rheumatism.

[224]  M. Hartmann,et al.  S100A12 Is Expressed Exclusively by Granulocytes and Acts Independently from MRP8 and MRP14* , 1999, The Journal of Biological Chemistry.

[225]  J. Launay,et al.  MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants , 2010, Science.

[226]  C. Heizmann,et al.  Structural and functional insights into RAGE activation by multimeric S100B , 2007, The EMBO journal.

[227]  C. Heizmann,et al.  The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. , 2006, Gastroenterology.

[228]  C. Heizmann,et al.  Specific Citrullination Causes Assembly of a Globular S100A3 Homotetramer , 2008, Journal of Biological Chemistry.

[229]  D. Foell,et al.  Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells1 , 2008, The Journal of Immunology.

[230]  J. Simard,et al.  Induction of neutrophil degranulation by S100A9 via a MAPK‐dependent mechanism , 2010, Journal of leukocyte biology.

[231]  G. Shaw,et al.  Calcium-dependent and -independent interactions of the S100 protein family. , 2006, The Biochemical journal.

[232]  C. Yu,et al.  Molecular level interactions of S100A13 with amlexanox: inhibitor for formation of the multiprotein complex in the nonclassical pathway of acidic fibroblast growth factor. , 2010, Biochemistry.

[233]  R. Natarajan,et al.  Increased expression of cyclooxygenase-2 in human pancreatic islets treated with high glucose or ligands of the advanced glycation endproduct-specific receptor (AGER), and in islets from diabetic mice , 2005, Diabetologia.

[234]  L. Puybasset,et al.  Prognosis Value of Plasma S100B Protein Levels after Subarachnoid Aneurysmal Hemorrhage , 2006, Anesthesiology.

[235]  D. Foell,et al.  RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis , 2008, Carcinogenesis.

[236]  J. Goyette,et al.  Mast Cell and Monocyte Recruitment by S100A12 and Its Hinge Domain* , 2008, Journal of Biological Chemistry.

[237]  A. Kleindienst,et al.  A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. , 2006, Journal of neurotrauma.

[238]  V. Berezin,et al.  Molecular Mechanisms of Ca2+ Signaling in Neurons Induced by the S100A4 Protein , 2006, Molecular and Cellular Biology.

[239]  T. Leanderson,et al.  Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides , 2009, PLoS biology.

[240]  R. Colello,et al.  Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury. , 2005, Journal of neurotrauma.

[241]  M. Brown,et al.  Criteria for a Clinically Informative Serum Biomarker in Acute Ischaemic Stroke: A Review of S100B , 2009, Cerebrovascular Diseases.

[242]  L. Walker,et al.  The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration , 2011, Neuroscience.

[243]  W. Nacken,et al.  Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans , 2009, PLoS pathogens.

[244]  D. Hume,et al.  A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo. , 1999, Journal of immunology.

[245]  D. Villines,et al.  Ala42S100A8 ameliorates psychological-stress impaired cutaneous wound healing , 2009, Brain, Behavior, and Immunity.

[246]  B. Bogerts,et al.  Elevated S100B levels in schizophrenia are associated with insulin resistance , 2010, Molecular Psychiatry.

[247]  L. V. Van Eldik,et al.  S100β Stimulates Inducible Nitric Oxide Synthase Activity and mRNA Levels in Rat Cortical Astrocytes (*) , 1996, The Journal of Biological Chemistry.

[248]  D. Zimonjic,et al.  DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism. , 2011, Cancer research.

[249]  S. Ramsey,et al.  Mechanisms of Urokinase Plasminogen Activator (uPA)-mediated Atherosclerosis , 2011, The Journal of Biological Chemistry.

[250]  Xiaodan Wang,et al.  S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. , 2003, Diabetes.

[251]  M. Fagerhol,et al.  Calprotectin inhibits matrix metalloproteinases by sequestration of zinc , 2001, Molecular pathology : MP.

[252]  Eric P. Skaar,et al.  Metal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses , 2008, Science.

[253]  Alexander D. MacKerell,et al.  Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction. , 2004, Journal of medicinal chemistry.

[254]  P. Madureira,et al.  Regulation of S100A10 by the PML-RAR-α oncoprotein. , 2011, Blood.

[255]  R. Kretsinger,et al.  Refinement of the structure of carp muscle calcium-binding parvalbumin by model building and difference Fourier analysis. , 1976, Journal of molecular biology.

[256]  Tony S. Tao,et al.  Proinflammatory properties of the human S100 protein S100A12 , 2001, Journal of leukocyte biology.

[257]  S. Fulle,et al.  Human muscle satellite cells show age-related differential expression of S100B protein and RAGE , 2011, AGE.

[258]  K. Kaibuchi,et al.  S100P Is a Novel Interaction Partner and Regulator of IQGAP1* , 2010, The Journal of Biological Chemistry.

[259]  J. L. Hansen,et al.  S100A4: a common mediator of epithelial–mesenchymal transition, fibrosis and regeneration in diseases? , 2008, Journal of molecular medicine.

[260]  C. Heizmann,et al.  S100A5: a marker of recurrence in WHO grade I meningiomas , 2004, Neuropathology and applied neurobiology.

[261]  M. Rigo,et al.  S100B secretion is stimulated by IL-1β in glial cultures and hippocampal slices of rats: Likely involvement of MAPK pathway , 2009, Journal of Neuroimmunology.

[262]  L. Pleštilová,et al.  Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis , 2011, Arthritis research & therapy.

[263]  F. Collart,et al.  A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases. , 1989, The Journal of biological chemistry.

[264]  David J Weber,et al.  Role of the C-terminal extension in the interaction of S100A1 with GFAP, tubulin, the S100A1- and S100B-inhibitory peptide, TRTK-12, and a peptide derived from p53, and the S100A1 inhibitory effect on GFAP polymerization. , 1999, Biochemical and biophysical research communications.

[265]  S. Heinemann,et al.  Current inhibition of human EAG1 potassium channels by the Ca2+ binding protein S100B , 2010, FEBS letters.

[266]  Qing-hua Zhang,et al.  Effects of S100A9 in a rat model of asthma and in isolated tracheal spirals. , 2010, Biochemical and biophysical research communications.

[267]  T. Loennechen,et al.  Dysregulation of Matrix Metalloproteinases and their Tissue Inhibitors by S100A4 , 2008, Connective tissue research.

[268]  J. Tsoporis,et al.  Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease , 2010, Cardiovascular psychiatry and neurology.

[269]  Lianbo Yu,et al.  Tumor-suppressive Effects of Psoriasin (S100A7) Are Mediated through the β-Catenin/T Cell Factor 4 Protein Pathway in Estrogen Receptor-positive Breast Cancer Cells* , 2011, The Journal of Biological Chemistry.

[270]  M. Völkers,et al.  S100A1: A Regulator of Striated Muscle Sarcoplasmic Reticulum Ca2+ Handling, Sarcomeric, and Mitochondrial Function , 2010, Journal of biomedicine & biotechnology.

[271]  R. Donato,et al.  S100B in myoblasts regulates the transition from activation to quiescence and from quiescence to activation and reduces apoptosis. , 2011, Biochimica et biophysica acta.

[272]  N. Hogg,et al.  The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. , 1998, Journal of immunology.

[273]  Alexander D. MacKerell,et al.  Design of Inhibitors for S100B. , 2005, Current topics in medicinal chemistry.

[274]  Kozo Nakamura,et al.  S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes , 2007, EMBO reports.

[275]  C. Klee,et al.  Calcium as a cellular regulator , 1999 .

[276]  G. Baumann,et al.  RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1. , 2011, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[277]  F. Brozzi,et al.  S100B Protein Regulates Astrocyte Shape and Migration via Interaction with Src Kinase , 2009, Journal of Biological Chemistry.

[278]  Increased levels of serum S100B protein in critically ill patients without brain injury , 2005, Shock.

[279]  M. Grigorian,et al.  Metastasis-Inducing S100A4 and RANTES Cooperate in Promoting Tumor Progression in Mice , 2010, PloS one.

[280]  F. Michetti,et al.  Perinatal S100B Protein Assessment in Human Unconventional Biological Fluids: A Minireview and New Perspectives , 2010, Cardiovascular psychiatry and neurology.

[281]  R. Shoemaker,et al.  Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis. , 2011, Neoplasia.

[282]  K. Bornfeldt,et al.  S100A8 and S100A9 in cardiovascular biology and disease. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[283]  A. Belli,et al.  S100B in neuropathologic states: The CRP of the brain? , 2007, Journal of neuroscience research.

[284]  R. Donato Calcium-independent, pH-regulated effects of S-100 proteins on assembly-disassembly of brain microtubule protein in vitro. , 1988, The Journal of biological chemistry.

[285]  B. Bogerts,et al.  Human CD8+ T cells and NK cells express and secrete S100B upon stimulation , 2011, Brain, Behavior, and Immunity.

[286]  W. Chazin,et al.  Implication of extracellular zinc exclusion by recombinant human calprotectin (MRP8 and MRP14) from target cells in its apoptosis-inducing activity. , 2002, Mediators of inflammation.

[287]  A. Filipek,et al.  S100A6 - new facts and features. , 2009, Biochemical and biophysical research communications.

[288]  N. Kaminski,et al.  Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. , 2012, American journal of respiratory and critical care medicine.

[289]  Jens Pietzsch,et al.  Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo. , 2010, The international journal of biochemistry & cell biology.

[290]  A. Marshall,et al.  Lost in migration , 2010, Nature Biotechnology.

[291]  X. Chen,et al.  Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system , 2003, Nature Medicine.

[292]  G. Slaughter,et al.  S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation. , 2012, Journal of molecular and cellular cardiology.

[293]  C. Bernardini,et al.  The S100B protein in biological fluids: more than a lifelong biomarker of brain distress , 2012, Journal of neurochemistry.

[294]  D. Zimmer,et al.  The Qγ component of intra‐membrane charge movement is present in mammalian muscle fibres, but suppressed in the absence of S100A1 , 2009, The Journal of physiology.

[295]  V. Vives,et al.  Visualization of S100B‐positive neurons and glia in the central nervous system of EGFP transgenic mice , 2003, The Journal of comparative neurology.

[296]  James T. Elder,et al.  EGF stimulates transcription of CaN19 (S100A2) in HaCaT keratinocytes. , 1998, The Journal of investigative dermatology.

[297]  C. Geczy,et al.  S100A8 modulates mast cell function and suppresses eosinophil migration in acute asthma. , 2011, Antioxidants & redox signaling.

[298]  W. Nacken,et al.  The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells , 2010, Nature Medicine.

[299]  R. Ni,et al.  High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker , 2012, Medical Oncology.

[300]  J. Goyette,et al.  Pleiotropic Roles of S100A12 in Coronary Atherosclerotic Plaque Formation and Rupture1 , 2009, The Journal of Immunology.

[301]  J. Simard,et al.  Damage-Associated Molecular Pattern S100A9 Increases Bactericidal Activity of Human Neutrophils by Enhancing Phagocytosis , 2011, The Journal of Immunology.

[302]  L. V. Van Eldik,et al.  Increased susceptibility of S100B transgenic mice to perinatal hypoxia‐ischemia , 2004, Annals of neurology.

[303]  A. Enk,et al.  RAGE signaling sustains inflammation and promotes tumor development , 2008, The Journal of experimental medicine.

[304]  R. Montironi,et al.  Expression of S100 protein family members in the pathogenesis of bladder tumors. , 2007, Anticancer research.

[305]  C. Gottfried,et al.  Gap junction inhibitors modulate S100B secretion in astrocyte cultures and acute hippocampal slices , 2009, Journal of neuroscience research.

[306]  D. Souza,et al.  Increased S100B serum levels in dilated cardiomyopathy patients. , 2007, Journal of cardiac failure.

[307]  C. Heizmann,et al.  S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. , 2004, Biochemical and biophysical research communications.

[308]  Wei Liu,et al.  S100B attenuates microglia activation in gliomas: Possible role of STAT3 pathway , 2011, Glia.

[309]  M. Bootman,et al.  Defective chemoattractant-induced calcium signalling in S100A9 null neutrophils. , 2007, Cell calcium.

[310]  David J Weber,et al.  S100A1 and Calmodulin Compete for the Same Binding Site on Ryanodine Receptor* , 2008, Journal of Biological Chemistry.

[311]  Kjetil Boye,et al.  S100A4 and metastasis: a small actor playing many roles. , 2010, The American journal of pathology.

[312]  R. Kretsinger,et al.  Cell signaling, beyond cytosolic calcium in eukaryotes. , 2009, Journal of inorganic biochemistry.

[313]  R. Donato,et al.  S100B protects LAN‐5 neuroblastoma cells against Aβ amyloid‐induced neurotoxicity via RAGE engagement at low doses but increases Aβ amyloid neurotoxicity at high doses , 2006, Journal of neuroscience research.

[314]  Hulun Li,et al.  Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune myasthenia gravis symptoms. , 2011, Clinical immunology.

[315]  B. Nawrot,et al.  S100A6 binds p53 and affects its activity. , 2009, The international journal of biochemistry & cell biology.

[316]  F. Michetti,et al.  S100b protein concentrations in amniotic fluid correlate with gestational age and with cerebral ultrasound scanning results in healthy fetuses. , 2001, Clinical chemistry.

[317]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[318]  W. Nacken,et al.  Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock , 2007, Nature Medicine.

[319]  R. Donato Perspectives in S-100 protein biology. Review article. , 1991, Cell calcium.

[320]  D. Foell,et al.  S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules , 2007, Journal of leukocyte biology.

[321]  P. Schlag,et al.  Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients. , 2011, The Journal of molecular diagnostics : JMD.

[322]  S. Almo,et al.  S100A4 Regulates Macrophage Chemotaxis , 2010, Molecular biology of the cell.

[323]  R. Donato,et al.  Effects of calcium‐binding proteins (S‐100ao, S‐100a, S‐100b) on desmin assembly in vitro , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[324]  W. Nacken,et al.  The arachidonic acid‐binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac‐2 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[325]  T. Tanaka,et al.  Novel specific chemtactic receptor for S100L protein on guinea pig eosinophils. , 1996, Biochemical and biophysical research communications.

[326]  J. Palefsky,et al.  S100A8 Triggers Oxidation-sensitive Repulsion of Neutrophils , 2006, Journal of dental research.

[327]  Zhihua Liu,et al.  A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway. , 2009, The Biochemical journal.

[328]  C. Gottfried,et al.  S100B Secretion in Acute Brain Slices: Modulation by Extracellular Levels of Ca2+ and K+ , 2009, Neurochemical Research.

[329]  I. Thorey,et al.  A Novel Regulator of Telomerase , 2007, Journal of Biological Chemistry.

[330]  David J Weber,et al.  Augmentation of Cav1 channel current and action potential duration after uptake of S100A1 in sympathetic ganglion neurons. , 2009, American journal of physiology. Cell physiology.

[331]  A. Hauschild,et al.  Biomarkers in melanoma , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[332]  R. Anderson,et al.  Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. , 2001, The Annals of thoracic surgery.

[333]  M. Sakaguchi,et al.  S100A11, an dual mediator for growth regulation of human keratinocytes. , 2008, Molecular biology of the cell.

[334]  David J Weber,et al.  Two functional S100A4 monomers are necessary for regulating nonmuscle myosin-IIA and HCT116 cell invasion. , 2011, Biochemistry.

[335]  A. Hill,et al.  HOXC11–SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib , 2011, British Journal of Cancer.

[336]  G. Makhatadze,et al.  Molecular characterization and tissue distribution of a novel member of the S100 family of EF-hand proteins. , 2001, Biochemistry.

[337]  P. Rouleau,et al.  Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion 1 , 2003, The Journal of Immunology.

[338]  R. Donato RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. , 2007, Current molecular medicine.

[339]  F. Michetti,et al.  S100B protein increases in human blood and urine during stressful activity , 2010, Clinical chemistry and laboratory medicine.

[340]  David J Weber,et al.  S100A4, a Mediator of Metastasis* , 2006, Journal of Biological Chemistry.

[341]  W. Tan,et al.  Functional role of S100A14 genetic variants and their association with esophageal squamous cell carcinoma. , 2009, Cancer research.

[342]  P. Tessier,et al.  S100A9 mediates neutrophil adhesion to fibronectin through activation of beta2 integrins. , 2007, Biochemical and biophysical research communications.

[343]  R. Donato,et al.  S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond , 2010, Cardiovascular psychiatry and neurology.

[344]  F. Brozzi,et al.  S100B Increases Proliferation in PC12 Neuronal Cells and Reduces Their Responsiveness to Nerve Growth Factor via Akt Activation* , 2005, Journal of Biological Chemistry.

[345]  D. Scudiero,et al.  Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. , 2011, Journal of the National Cancer Institute.

[346]  J. Schröder,et al.  The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. , 2009, The Journal of investigative dermatology.

[347]  H. Kawai,et al.  Prognostic impact of S100A9 overexpression in non-small cell lung cancer , 2011, Tumor Biology.

[348]  C. Heizmann,et al.  S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). , 2004, Biochemical and biophysical research communications.

[349]  M. S. Benfato,et al.  Serum S100B protein is increased in fasting rats. , 2006, Archives of medical research.

[350]  L. Lanting,et al.  Regulation of Cyclooxygenase-2 Expression in Monocytes by Ligation of the Receptor for Advanced Glycation End Products* , 2003, Journal of Biological Chemistry.

[351]  A. Remppis,et al.  Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products , 2006 .

[352]  H. Redl,et al.  Hemorrhagic Shock Induces an S 100 B Increase Associated With Shock Severity , 2003, Shock.

[353]  D. Foell,et al.  Carboxylated N‐glycans on RAGE promote S100A12 binding and signaling , 2010, Journal of cellular biochemistry.

[354]  A. Tort,et al.  Specificity and sensitivity of S100B levels in amniotic fluid for Down syndrome diagnosis. , 2004, Life sciences.

[355]  Hugo M. Botelho,et al.  Natural and amyloid self‐assembly of S100 proteins: structural basis of functional diversity , 2010, The FEBS journal.

[356]  L. Juliano,et al.  Analgesic properties of S100A9 C‐terminal domain: a mechanism dependent on calcium channel inhibition , 2009, Fundamental & clinical pharmacology.

[357]  K. Hahn,et al.  A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics. , 2008, Biochemistry.

[358]  G. Shaw,et al.  The S100A10-Annexin A2 Complex Provides a Novel Asymmetric Platform for Membrane Repair* , 2011, The Journal of Biological Chemistry.

[359]  Meihong Lin,et al.  Induction of S100A9 Gene Expression by Cytokine Oncostatin M in Breast Cancer Cells Through the STAT3 Signaling Cascade , 2004, Breast Cancer Research and Treatment.

[360]  S. Itohara,et al.  Glial protein S100B modulates long-term neuronal synaptic plasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[361]  C. Overgaard,et al.  S100B modulates the hemodynamic response to norepinephrine stimulation. , 2009, American journal of hypertension.

[362]  D. Waisman,et al.  Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites. , 2011, Cancer research.

[363]  T. Arumugam,et al.  Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. , 2006, Journal of the National Cancer Institute.

[364]  E. Peskind,et al.  S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10 , 2009, PloS one.

[365]  T. Bisogno,et al.  Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro , 2007, Journal of Molecular Medicine.

[366]  R. Schmidhammer,et al.  Circulating S100B is increased after bilateral femur fracture without brain injury in the rat. , 2003, British journal of anaesthesia.

[367]  M. Wiesmann,et al.  S-100B is increased in melancholic but not in non-melancholic major depression. , 2001, Journal of affective disorders.

[368]  J. Roth,et al.  High expression of myeloid‐related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy , 2004, Immunology.

[369]  P. Hart,et al.  S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity. , 2007, The Journal of allergy and clinical immunology.

[370]  K. Wilson,et al.  The crystal structures of human S100A12 in apo form and in complex with zinc: new insights into S100A12 oligomerisation. , 2009, Journal of molecular biology.

[371]  M. Berridge,et al.  Calcium signalling: dynamics, homeostasis and remodelling , 2003, Nature reviews. Molecular cell biology.

[372]  K. Walley,et al.  S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products , 2008, Circulation research.

[373]  David J Weber,et al.  Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B. , 2006, Biochimica et biophysica acta.

[374]  A. Fersht,et al.  Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53. , 2009, Journal of molecular biology.

[375]  Zhihua Liu,et al.  S100A14 Stimulates Cell Proliferation and Induces Cell Apoptosis at Different Concentrations via Receptor for Advanced Glycation End Products (RAGE) , 2011, PloS one.

[376]  David J Weber,et al.  The Calcium-Dependent Interaction of S100B with Its Protein Targets , 2010, Cardiovascular psychiatry and neurology.

[377]  Saeid Ghavami,et al.  S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase‐dependent pathway , 2008, Journal of leukocyte biology.

[378]  C. Heizmann,et al.  Dissimilar effect of perming and bleaching treatments on cuticles: advanced hair damage model based on elution and oxidation of S100A3 protein. , 2005, Journal of the Society of Cosmetic Chemists.

[379]  David J Weber,et al.  S100A1 Binds to the Calmodulin-binding Site of Ryanodine Receptor and Modulates Skeletal Muscle Excitation-Contraction Coupling* , 2008, Journal of Biological Chemistry.

[380]  F. Brozzi,et al.  S100B's double life: intracellular regulator and extracellular signal. , 2009, Biochimica et biophysica acta.

[381]  A. Harmar,et al.  Interdependent Serotonin Transporter and Receptor Pathways Regulate S100A4/Mts1, a Gene Associated With Pulmonary Vascular Disease , 2005, Circulation research.

[382]  R. Terkeltaub,et al.  Inflammation-Induced Chondrocyte Hypertrophy Is Driven by Receptor for Advanced Glycation End Products1 , 2005, The Journal of Immunology.

[383]  S. Kyurkchiev,et al.  FGF-1 and S100A13 possibly contribute to angiogenesis in endometriosis. , 2005, Journal of reproductive immunology.

[384]  D. Villines,et al.  S100A8 and S100A9 inhibit neutrophil oxidative metabolism in-vitro: Involvement of adenosine metabolites , 2010, Free radical research.

[385]  A. Remppis,et al.  S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[386]  E. Postal,et al.  Epithelioid cells from foreign‐body granuloma selectively express the calcium‐binding protein MRP‐14, a novel down‐regulatory molecule of macrophage activation , 1997, Journal of leukocyte biology.

[387]  W. Trojaborg,et al.  RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[388]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[389]  P. Libby,et al.  Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. , 2008, American heart journal.

[390]  C. Melchior,et al.  An Essential Role of STIM1, Orai1, and S100A8–A9 Proteins for Ca2+ Signaling and FcγR-Mediated Phagosomal Oxidative Activity , 2011, The Journal of Immunology.

[391]  M. Wiesmann,et al.  Elevated plasma levels of S-100b protein in schizophrenic patients , 1999, Biological Psychiatry.

[392]  R. Donato,et al.  S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release* , 2011, The Journal of Biological Chemistry.

[393]  F. Berger,et al.  Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. , 2010, Rheumatology.

[394]  P. Hajduk,et al.  Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.

[395]  T. Arumugam,et al.  S100P: a novel therapeutic target for cancer , 2011, Amino Acids.

[396]  H. Kato,et al.  Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson’s disease , 2008, Metabolic Brain Disease.

[397]  K. Yamaguchi,et al.  Novel S100 proteins in human esophageal epithelial cells: CAAF1 expression is associated with cell growth arrest. , 1998, Archives of histology and cytology.

[398]  C. Geczy,et al.  ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS. , 2009, Anti-inflammatory & anti-allergy agents in medicinal chemistry.

[399]  D. Foell,et al.  Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[400]  J. Grigull,et al.  Nuclear S100A7 Is Associated with Poor Prognosis in Head and Neck Cancer , 2010, PloS one.

[401]  R. Donato,et al.  S100b expression in and effects on microglia , 2001, Glia.

[402]  A. Kapsoritakis,et al.  Calprotectin, Calgranulin C, and Other Members of the S100 Protein Family in Inflammatory Bowel Disease , 2011, Digestive Diseases and Sciences.

[403]  D. Turner,et al.  Update of fecal markers of inflammation in inflammatory bowel disease , 2011, Journal of gastroenterology and hepatology.

[404]  P. Svenningsson,et al.  Regulation of fibrinolysis by S100A10 in vivo. , 2011, Blood.

[405]  David J Weber,et al.  Molecular mechanisms of S100‐target protein interactions , 2003, Microscopy research and technique.

[406]  A. Schmidt,et al.  RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. , 2007, Investigative ophthalmology & visual science.

[407]  F. Michetti,et al.  Amniotic fluid levels of S100B protein in normal and trisomy-21 foetuses. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[408]  F. Michetti,et al.  S100B protein levels in saliva: correlation with gestational age in normal term and preterm newborns. , 2005, Clinical biochemistry.

[409]  Gene Kim,et al.  S100A12 in Vascular Smooth Muscle Accelerates Vascular Calcification in Apolipoprotein E–Null Mice by Activating an Osteogenic Gene Regulatory Program , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[410]  B. Bogerts,et al.  S100B serum levels are closely correlated with body mass index: An important caveat in neuropsychiatric research , 2010, Psychoneuroendocrinology.

[411]  W. Nacken,et al.  Interaction between S100A8/A9 and Annexin A6 Is Involved in the Calcium-induced Cell Surface Exposition of S100A8/A9* , 2008, Journal of Biological Chemistry.